PER 2.35% 8.7¢ percheron therapeutics limited

So we have 668m shares on issue. Cash is approximately A$18m.At...

  1. 300 Posts.
    lightbulb Created with Sketch. 833
    So we have 668m shares on issue.

    Cash is approximately A$18m.

    At 9c we have a market cap of A$60mAt AUD/USD at 62c, this equates to an enterprise value of US$26m

    After the results across DMD, Limb Girdle, Long Covid, the potential of the combination studies, the high likelihood of our P2b being an approve able trial, witnessing Sarepta sales of >US$200m for the QUARTER for drugs that show no clinical efficacy..

    The low valuation of this company is a disgrace.

    I would love to know lots of different peoples opinions on what key catalysts will improve the outlook for the share price?

    Thanks in Advance.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.7¢
Change
0.002(2.35%)
Mkt cap ! $78.43M
Open High Low Value Volume
8.6¢ 8.9¢ 8.5¢ $53.40K 614.3K

Buyers (Bids)

No. Vol. Price($)
1 49999 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.9¢ 67263 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.